These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4082083)

  • 21. Effect of xanthinol nicotinate treatment on platelet aggregation.
    Seidel G; Endell W
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):139-43. PubMed ID: 844933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms involved in adenosine triphosphate--induced platelet aggregation in whole blood.
    Stafford NP; Pink AE; White AE; Glenn JR; Heptinstall S
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1928-33. PubMed ID: 12893689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line.
    Esumi N; Todo S; Imashuku S
    Cancer Res; 1987 Apr; 47(8):2129-35. PubMed ID: 3829002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanism of action of biogenic chloramines and hypochlorite on initial aggregation of blood platelets].
    Murina MA; Savel'eva EL; Roshchupkin DI
    Biofizika; 2006; 51(2):299-305. PubMed ID: 16637337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet pro-aggregatory effects of CD40L monoclonal antibody.
    Mirabet M; Barrabés JA; Quiroga A; Garcia-Dorado D
    Mol Immunol; 2008 Feb; 45(4):937-44. PubMed ID: 17959249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood.
    Glenn JR; White AE; Johnson A; Fox SC; Behan MW; Dolan G; Heptinstall S
    Platelets; 2005; 16(3-4):159-70. PubMed ID: 16011960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine diphosphate induced platelet aggregation and release reaction in heparinized platelet rich plasma and the influence of added citrate.
    Heptinstall S; Mulley GP
    Br J Haematol; 1977 Aug; 36(4):565-71. PubMed ID: 889719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of platelets with standard heparin and low molecular weight fractions.
    Dunn FW; Soria C; Thomaidis A; Soria J; Dupuy E; Bellucci S; Tobelem G
    Nouv Rev Fr Hematol (1978); 1984; 26(4):249-53. PubMed ID: 6089103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Difference in inhibitory actions of products of the myeloperoxidase- catalyzed reaction on initial aggregation of activated platelets].
    Rpshchupkin DI; Berzhitskaia VV; Murina MA
    Biofizika; 1998; 43(2):323-8. PubMed ID: 9591107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
    Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diadenosine 5',5"'-P1,P3-triphosphate in eukaryotic cells: identification and quantitation.
    Ogilvie A; Jakob P
    Anal Biochem; 1983 Oct; 134(2):382-92. PubMed ID: 6650824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rabbit platelet injury by soluble antigen and antibody. II. Platelet aggregation in heparinized plasma and citrated plasma, relationship to ADP and inhibition by cobra factor.
    Marney SR
    J Immunol; 1971 Jan; 106(1):82-90. PubMed ID: 5543731
    [No Abstract]   [Full Text] [Related]  

  • 34. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
    Storey RF; May JA; Heptinstall S
    Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catabolism of Ap4A and Ap3A in whole blood. The dinucleotides are long-lived signal molecules in the blood ending up as intracellular ATP in the erythrocytes.
    Lüthje J; Ogilvie A
    Eur J Biochem; 1988 Apr; 173(1):241-5. PubMed ID: 3356191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of a novel soluble nucleotide phospho-hydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology.
    Birk AV; Bubman D; Broekman MJ; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
    J Lab Clin Med; 2002 Feb; 139(2):116-24. PubMed ID: 11919550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
    Yamamoto K; Sekiguchi E; Takatani O
    Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes.
    Michno A; Bielarczyk H; Pawełczyk T; Jankowska-Kulawy A; Klimaszewska J; Szutowicz A
    Diabetes; 2007 Feb; 56(2):462-7. PubMed ID: 17259392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of heparin on the aggregation function of thrombocytes].
    Zhukovskaia ES; Blindar' VN
    Farmakol Toksikol; 1984; 47(5):36-40. PubMed ID: 6500033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.